Cui Hao, Schaff Hartzell V, Dearani Joseph A, Lahr Brian D, Viehman Jason K, Geske Jeffrey B, Nishimura Rick A, Ommen Steve R
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
J Thorac Cardiovasc Surg. 2021 Mar;161(3):997-1006.e3. doi: 10.1016/j.jtcvs.2020.08.066. Epub 2020 Aug 25.
To evaluate the outcomes after septal myectomy in patients with obstructive hypertrophic cardiomyopathy according to atrial fibrillation and surgical ablation of atrial fibrillation.
We reviewed patients with obstructive hypertrophic cardiomyopathy who underwent septal myectomy at the Mayo Clinic from 2001 to 2016. History of atrial fibrillation was obtained from patient histories and electrocardiograms. All-cause mortality was the primary end point.
A total of 2023 patients underwent septal myectomy, of whom 394 (19.5%) had at least 1 episode of atrial fibrillation preoperatively. Among patients with atrial fibrillation, 76 (19.3%) had only 1 known episode, 278 (70.6%) had recurrent paroxysmal atrial fibrillation, and 40 (10.2%) had persistent atrial fibrillation. Surgical ablation was performed in 190 patients at the time of septal myectomy, including 148 with pulmonary vein isolation and 42 with the classic maze procedure. Among all patients, operative mortality was 0.4%, and there were no early deaths in patients undergoing surgical ablation. Over a median follow-up of 5.6 years, patients with preoperative atrial fibrillation had increased mortality (hazard ratio, 1.36; 95% confidence interval, 0.97-1.91; P = .070) after multivariable adjustment for comorbidities. When considering the impact of atrial fibrillation with or without surgical treatment, the adjusted hazard ratio for mortality in patients undergoing ablation compared with no ablation was 0.93 (95% confidence interval, 0.52-1.69; P = .824).
Atrial fibrillation is present preoperatively in one-fifth of patients with obstructive hypertrophic cardiomyopathy undergoing myectomy and showed a trend toward higher all-cause mortality. Survival of patients undergoing septal myectomy with preoperative atrial fibrillation was similar between those who did and did not receive concomitant surgical ablation.
根据心房颤动及心房颤动外科消融情况,评估梗阻性肥厚型心肌病患者行室间隔心肌切除术后的结局。
我们回顾了2001年至2016年在梅奥诊所接受室间隔心肌切除术的梗阻性肥厚型心肌病患者。心房颤动病史通过患者病历和心电图获取。全因死亡率是主要终点。
共有2023例患者接受了室间隔心肌切除术,其中394例(19.5%)术前至少有1次心房颤动发作。在心房颤动患者中,76例(19.3%)仅有1次已知发作,278例(70.6%)有复发性阵发性心房颤动,40例(10.2%)有持续性心房颤动。190例患者在室间隔心肌切除术时进行了外科消融,其中148例行肺静脉隔离,42例行经典迷宫手术。在所有患者中,手术死亡率为0.4%,接受外科消融的患者无早期死亡。中位随访5.6年,对合并症进行多变量调整后,术前有心房颤动的患者死亡率增加(风险比,1.36;95%置信区间,0.97 - 1.91;P = 0.070)。在考虑有无手术治疗的心房颤动的影响时,接受消融与未接受消融的患者相比,调整后的死亡风险比为0.93(95%置信区间,0.52 - 1.69;P = 0.824)。
在接受心肌切除术的梗阻性肥厚型心肌病患者中,五分之一术前存在心房颤动,且全因死亡率有升高趋势。术前有心房颤动的患者,接受与未接受同期外科消融的室间隔心肌切除术后生存率相似。